Skip to main content

What the label lists and what reports show

Norethindrone side effects

Norethindrone's FDA label: “Menstrual irregularity is the most frequently reported side effect.” FAERS holds 5,466 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is nausea (460 reports).

  • Generic listed

Check it at the source: the norethindrone FDA label on DailyMed (effective January 31, 2026, Glenmark Pharmaceuticals Inc., USA); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

Menstrual irregularity is the most frequently reported side effect.

From the label: adverse reactions, continued

Adverse reactions reported with the use of POPs include: • Menstrual irregularity is the most frequently reported side effect. • Frequent and irregular bleeding are common, while long duration of bleeding episodes and amenorrhea are less likely. • Headache, breast tenderness, nausea, and dizziness are increased among progestin-only oral contraceptive users in some studies. • Androgenic side effects such as acne, hirsutism, and weight gain occur rarely. The following adverse reactions were also reported in clinical trials or during post-marketing experience: Gastrointestinal Disorders: vomiting, abdominal pain; General Disorders and Administration Site Conditions: fatigue, edema; Psychiatric Disorders: depression, nervousness; Musculoskeletal and Connective Tissue Disorders: pain in extremity; Reproductive System and Breast Disorders: genital discharge; breast pain, menstruation delayed, suppressed lactation, vaginal hemorrhage, menorrhagia, withdrawal bleed when product is stopped; Immune System Disorders: anaphylactic/anaphylactoid reaction, hypersensitivity; Hepatobiliary Disorders: hepatitis, jaundice cholestatic; Skin and Subcutaneous Tissue Disorders: alopecia, rash, rash pruritic.

Source: FDA drug label, Glenmark Pharmaceuticals Inc., USA, effective January 31, 2026 (SPL set 0d2f8fea-3675-40d2-afd9-9fcb148dbd4b), via openFDA; the full label on DailyMed

What do FAERS reports show?

5,466 reports list norethindrone among the medicines taken, each a report of something that happened, not proof the medicine caused it; 83 are coded as a death and 971 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 22 reactions below, 6 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Nausea (named in the label)460
  • Headache (named in the label)437
  • Hot Flush369
  • Fatigue (named in the label)334
  • Drug Ineffective (a use or a product term, not a reaction)331
  • Pain312
  • Off Label Use (a use or a product term, not a reaction)309
  • Vaginal Haemorrhage278
  • Abdominal Pain (named in the label)269
  • Diarrhoea234
  • Arthralgia231
  • Dizziness (named in the label)221
  • Vomiting (named in the label)210
  • Anxiety209
  • Migraine206
  • Depression199
  • Pelvic Pain180
  • Weight Increased178
  • Dyspnoea177
  • Insomnia176
  • Menorrhagia162
  • Product Dose Omission Issue (a use or a product term, not a reaction)162
  • Back Pain159
  • Mood Swings151
  • Muscle Spasms145

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Norethindrone: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions